Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine

Vaccine

Volumn 33, Issue 13, 2015, Pages 1518-1526

  Delrieu, Isabelle ^a   Leboulleux, Didier ^b   Ivinson, Karen ^c   Gessner, Bradford D ^a  

^a Agence de Médecine Préventive AMP   (France)

^b PATH   (France)

^c PATH   (Switzerland)

Author keywords

Cluster randomized trial; Malaria; Transmission blocking vaccine; Trial design

Indexed keywords

MALARIA VACCINE;

BED NET; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GAMETOCYTE; HUMAN; IMMUNOGENICITY; MALARIA CONTROL; MALARIA FALCIPARUM; MOSQUITO; PARASITE TRANSMISSION; PHASE 3 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAMPLE SIZE; STUDY DESIGN; VACCINATION; ANIMAL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MALARIA, FALCIPARUM; PHASE 3 CLINICAL TRIAL (TOPIC); SENTINEL SURVEILLANCE; STANDARDS; TRANSMISSION;

ANIMALS; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SENTINEL SURVEILLANCE;

EID: 84924956720     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.01.050     Document Type: Review

References (45)

1. World Health Organization World malaria report 2013 2013, http://www.who.int/malaria/publications/world_malaria_report_2013/en/.
2. World Health Organization Global plan for insecticide resistance management in malaria vectors (GPIRM) 2012 2012, http://whqlibdoc.who.int/publications/2012/9789241564472_eng.pdf.
3. World Health Organization Global report on antimalarial drug efficacy and drug resistance: 2000-2010 2010, http://whqlibdoc.who.int/publications/2010/9789241500470_eng.pdf?ua=1.
4. TDR Malaria transmission blocking vaccines: and ideal public good. A special report of the UNPD/World Bank/WHO special programme for Research and Training in Tropical Diseases (TDR). Publication n° TDR/RBM/MAL/VAC/2000.1 2000, TDR, Geneva.
5. The malERA Consultative Group on Vaccines A research agenda for malaria eradication: vaccines. PLoS Med 2011, 8(1):e1000398.
6. Malaria Vaccine Funders Group Malaria vaccine technology roadmap 2013, http://www.who.int/immunization/topics/malaria/vaccine_roadmap/TRM_update_nov13.pdf.
7. Winzeler E.A. Malaria research in the post-genomic era. Nature 2008, 455(October (7214)):751-756.
8. Targett G.A., Greenwood B.M. Malaria vaccines and their potential role in the elimination of malaria. Malar J 2008, 7(December (Suppl. 1)):S10. 10.1186/1475-2875-7-S1-S10.
9. Sinden R.E., Carter R., Drakeley C., Leroy D. The biology of sexual development of Plasmodium: the design and implementation of transmission-blocking strategies. Malar J 2012, 11(March (70)). 10.1186/1475-2875-11-70.
10. Blagborough A.M., Churcher T.S., Upton L.M., Ghani A.C., Gething P.W., Sinden R.E. Transmission-blocking interventions eliminate malaria from laboratory populations. Nat Commun 2013, 4(1812). 10.1038/ncomms2840.
11. Sarr J.B., Orlandi-Pradines E., Fortin S., Sow C., Cornelie S., Rogerie F., et al. Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays. Parasites Vectors 2011, 4(November (212)). 10.1186/1756-3305-4-212.
12. Ambrosino E., Dumoulin C., Orlandi-Pradines E., Remoue F., Toure-Baldé A., Tall A., et al. A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J 2010, 9(November (317)). 10.1186/1475-2875-9-317.
13. Corran P., Coleman P., Riley E., Drakeley C. Serology: a robust indicator of malaria transmission intensity?. Trends Parasitol 2007, 23:575-582. 10.1016/j.pt.2007.08.023.
14. Bousema T., Youssef R.M., Cook J., Cox J., Alegana V.A., Amran J., et al. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis 2010, 16(March (3)):392-399.
15. Bretscher M.T., Valsangiacomo F., Owusu-Agyei S., Penny M.A., Felger I., Smith T. Detectability of Plasmodium falciparum clones. Malar J 2010, 9:234. 10.1186/1475-2875-9-234.
16. Pinder M., Moorthy V.S., Mendis K., Brown G.V. MALVAC 2010 Report: Measures of Efficacy of Anti-malarial Interventions against Malaria Transmission 2010, http://www.who.int/immunization/research/meetings_workshops/MALVAC_2010_meeting_report.pdf.
17. Miura K., Deng B., Tullo G., Diouf A., Moretz S.E., Locke E., et al. Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays. PLOS ONE 2013, 8(3):e57909.
18. Bousema T., Churcher T.S., Morlais I., Dinglasan R.R. Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions?. Trends Parasitol 2013, 29(February (2)):53-59.
19. Chaki P.P., Mlacha Y., Msellemu D., Muhili A., Malishee A.D., Mtema Z.I., et al. An affordable, quality-assured community-based system for high-resolution entomological surveillance of vector mosquitoes that reflects human malaria infection risk patterns. Malar J 2012, 11(May (172)). 10.1186/1475-2875-11-172.
20. Sikaala C.H., Chinula D., Chanda J., Hamainza B., Mwenda M., Mukali I., et al. A cost-effective, community-based, mosquito-trapping scheme that captures spatial and temporal heterogeneities of malaria transmission in rural Zambia. Malar J 2014, 13(June (1)):225. 10.1186/1475-2875-13-225.
21. Tusting L.S., Bousema T., Smith D.L., Drakeley C. Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics. Adv Parasitol 2014, 84:151-208.
22. Bell A.S., Ranford-Cartwright L.C. A real-time PCR assay for quantifying Plasmodium falciparum infections in the mosquito vector. Int J Parasitol 2004, 34(June (7)):795-802.
23. Vaucher P. Designing Phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs. Vaccine 2009, 27(March (13)):1928-1931.
24. Dicko A., Konare M., Traore D., Testa J., Salamon R., Doumbo O., et al. The implementation of malaria intermittent preventive trial treatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control. Malar J 2012, 11(March (73)). 10.1186/1475-2875-11-73.
25. Schellenberg J.R., Maokola W., Shirima K., Manzi F., Mrisho M., Mushi A., et al. Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival. Malar J 2011, 10(December):387. 10.1186/1475-2875-10-387.
26. Bojang K.A., Akor F., Conteh L., Webb E., Bittaye O., Conway D.J., et al. Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med 2011, 8(February (2)):e1000409.
27. Cisse B., Cairns M., Faye E., NDiaye O., Faye B., Cames C., et al. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS ONE 2009, 4(September (9)):e7164.
28. Chandramohan D., Owusu-Agyei S., Carneiro I., Awine T., Amponsa-Achiano K., Mensah N., et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ 2005, 331(October (7519)):727-733.
29. Gamble C., Ekwaru P.J., Garner P., ter Kuile F.O. Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomized controlled trials. PLoS Med 2007, 4(March (3)):e107.
30. Hawley W.A., Phillips-Howard P.A., ter Kuile F.O., Terlouw D.J., Vulule J.M., Ombok M., et al. Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg 2003, 68(April (4 Suppl.)):121-127.
31. Browne E.N., Maude G.H., Binka F.N. The impact of insecticide-treated bednets on malaria and anaemia in pregnancy in Kassena-Nankana district, Ghana: a randomized controlled trial. Trop Med Int Health 2001, 6(September (9)):667-676.
32. Shekalaghe S.A., Drakeley C., van den Bosch S., ter Braak R., van den Bijllaardt W., Mwanziva C., et al. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J 2011, 10(August):247. 10.1186/1475-2875-10-247.
33. Tine R.C., Ndour C.T., Faye B., Cairns M., Sylla K., Ndiaye M., et al. Feasibility, safety and effectiveness of combining home based malaria management and seasonal malaria chemoprevention in children less than 10 years in Senegal: a cluster-randomised trial. Trans R Soc Trop Med Hyg 2014, 108(January (1)):13-21.
34. Corbel V., Martin Akogbeto M., Damien G.B., Djenontin A., Chandre F., Rogier C., et al. Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomized controlled trial. Lancet Infect Dis 2012, 12(August (8)):617-626.
35. Tine R.C., Faye B., Ndour C.T., Ndiaye J.L., Ndiaye M., Bassene C., et al. Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial. Malar J 2011, 10(December):358. 10.1186/1475-2875-10-358.
36. Bousema T., Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 2011, 24(April (2)):377-410.
37. Hayes R.J., Moulton L.H. Cluster randomized trials 2009, 45-64. CRC Press, Boca Raton, FL.
38. Griffin J.T., Hollingsworth T.D., Okell L.C., Churcher T.S., White M., Hinsley W., et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 2010, 7(August (8)). pii:e1000324. 10.1371/journal.pmed.1000324.
39. Smith T.A., Chitnis N., Briët O.J.T., Tanner M. Uses of mosquito-stage transmission-blocking vaccines against Plasmodium falciparum. Trends Parasitol 2011, 27(May (5)):190-196.
40. Hayes R.J., Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999, 28:3193-3196.
41. Hayes R.J., Moulton L.H. Cluster randomised trials: a practical approach 2009, Chapman and Hall/CRC, Boca Raton, FL.
42. Kelly-Hope L.A., McKenzie F.E. The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J 2009, 8(January):19. 10.1186/1475-2875-8-19.
43. Bousema T., Stevenson J., Baidjoe A., Stresman G., Griffin J.T., Kleinschmidt I., et al. The impact of hotspot-targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled trial. Trials 2013, 14(February):36. 10.1186/1745-6215-14-36.
44. Sokhna C., Ndiath M.O., Rogier C. The changes in mosquito vector behavior and the emerging resistance to insecticides will challenge the decline of malaria. Clin Microbiol Infect 2013, 19(October (10)):902-907.
45. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361(July (5)):455-467.